Non EU

Friedreich’s Ataxia Research Alliance – Award for Innovative Mindset (AIM)

Bandi, Friedrich's Araxia Research Alliance - FARA, Non EU /

AIM supports innovative, high-impact research that will foster new directions, bring new perspectives to the field, and address neglected issues in FA research. This RFP promotes the initial exploration of high-risk, high-gain, and potentially groundbreaking concepts in FA research. The proposed research project should be innovative and include a well-formulated, testable hypothesis. The presentation of […]

Friedreich’s Ataxia Research Alliance – Award for Innovative Mindset (AIM) Leggi tutto »

Alzheimer’s Drug Discovery Foundation – Prevention beyond the pipeline

Alzheimer's Drug Discovery Foundation, Bandi /

Through its Prevention beyond the pipeline Program, the ADDF seeks to support comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline. Duration: One year for epidemiological analyses Varies (multi-year) for clinical trials Average award: $50,000-$100,000 for epidemiological analyses

Alzheimer’s Drug Discovery Foundation – Prevention beyond the pipeline Leggi tutto »

Alzheimer’s Drug Discovery Foundation – Program to Accelerate Clinical Trials (PACT)

Alzheimer's Drug Discovery Foundation, Bandi /

L’obiettivo del bando è l’aumento del numero di trattamenti nuovi per la malattia di Alzheimer, le demenze correlate e l’invecchiamento cognitivo (studi clinici pilota basati su biomarker per i test di sicurezza di Alzheimer, così come i test di sicurezza di fase 1) Le proposte progettuali possono avere una durata variabile e il finanziamento massimo è

Alzheimer’s Drug Discovery Foundation – Program to Accelerate Clinical Trials (PACT) Leggi tutto »

Alzheimer’s Drug Discovery Foundation – Neuroimaging and CSF Biomarker development program

Alzheimer's Drug Discovery Foundation, Bandi /

Given the pathological heterogeneity of Alzheimer’s disease and related dementias, new biomarkers are needed to more accurately characterize specific underlying pathophysiology. This RFP seeks to support the development of CSF and neuroimaging biomarkers for multiple contexts of use (see below) that include but are not limited to: Clearly demonstrate target engagement for novel therapeutics The

Alzheimer’s Drug Discovery Foundation – Neuroimaging and CSF Biomarker development program Leggi tutto »

The National Institute for Health Care Management (NIHCM) Research Grants 2020

Bandi, NIHCM Foundation /

Purpose: To support innovative research that will advance the existing knowledge base in the areas of health care financing, delivery, management and/or policy. Studies must have strong potential to yield insights that can be used to have a positive impact on the U.S. health care system by reducing spending, improving quality of care, and/or expanding

The National Institute for Health Care Management (NIHCM) Research Grants 2020 Leggi tutto »

The Michael J.Fox Foundation for Parkinson’s Research – Bando Target Advancement Program

Bandi, Non EU, The Michael J. Fox Foundation /

The Target Advancement Program is open to industry and academic investigators proposing to build conclusive evidence to rationalize biological targets and pathways for Parkinson’s disease (PD) therapeutic development. Part of our Edmond J. Safra Core Programs for PD Research, this program will support projects focused on validating targets and defining pathways implicated in PD pathological processes

The Michael J.Fox Foundation for Parkinson’s Research – Bando Target Advancement Program Leggi tutto »

The Michael J.Fox Foundation for Parkinson’s Research – Bando Parkinson’s Pathway Biomarkers

Bandi, Non EU, The Michael J. Fox Foundation /

Currently, many efforts are focusing on understanding the role of various cellular processes/pathways in PD and uncovering novel targets within these pathways for therapeutic development. As such, sensitive biomarker readouts for these pathways will be critical for bridging the gap from basic to translational research and clinical trials. The Parkinson’s Pathway Biomarkers program is open

The Michael J.Fox Foundation for Parkinson’s Research – Bando Parkinson’s Pathway Biomarkers Leggi tutto »

The Michael J.Fox Foundation for Parkinson’s Research – Therapeutic Pipeline Program

Bandi, Non EU, The Michael J. Fox Foundation /

The Therapeutic Pipeline Program is open to industry and academic investigators proposing novel approaches or repositioning approved or clinically safe therapies from other disease indications. Part of our Edmond J. Safra Core Programs for PD Research, the Therapeutic Pipeline Program advances Parkinson’s disease therapeutic and intervention development along the pre-clinical and clinical path. Applications should focus on studies

The Michael J.Fox Foundation for Parkinson’s Research – Therapeutic Pipeline Program Leggi tutto »

AXA Research Fund – Exceptional Flash Call for Proposals on Covid-19

Bandi, Fraxa Research Foundation /

In response to the current Covid-19 crisis, the AXA Research Fund Team is launching a flash call for projects: Mitigating risk in the wake of the Covid-19 Pandemic.  Projects should focus on:  Protecting vulnerable populations from epidemics and catastrophes, including COVID-19: be it migrants, informal settlements, workers in the informal economy, isolated people, people with

AXA Research Fund – Exceptional Flash Call for Proposals on Covid-19 Leggi tutto »

Swartz Prize for Theoretical and Computational Neuroscience

Bandi, Society for Neuroscience /

The Swartz Prize, supported by the Swartz Foundation, honors an individual whose activities have produced a significant cumulative contribution to theoretical models or computational methods in neuroscience or who has made a particularly noteworthy recent advance in theoretical or computational neuroscience. Recipients receive a $30,000 prize and complimentary registration, transportation (economy air or ground), and

Swartz Prize for Theoretical and Computational Neuroscience Leggi tutto »

Torna in alto